AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $786,542 | -9.5% | 11,254 | -0.1% | 0.71% | +100.0% |
| Q4 2022 | $868,792 | +48.8% | 11,264 | -26.1% | 0.35% | +72.2% |
| Q2 2022 | $584,000 | -85.9% | 15,246 | -84.8% | 0.20% | -81.2% |
| Q1 2022 | $4,151,000 | +97.5% | 100,299 | +80.3% | 1.09% | +115.6% |
| Q4 2021 | $2,102,000 | +22.5% | 55,629 | +6.9% | 0.51% | +29.7% |
| Q3 2021 | $1,716,000 | +135.7% | 52,048 | +320.9% | 0.39% | +18.5% |
| Q1 2020 | $728,000 | -36.9% | 12,367 | +10.9% | 0.33% | -9.1% |
| Q4 2019 | $1,153,000 | +55.0% | 11,151 | -78.7% | 0.36% | +23.5% |
| Q1 2019 | $744,000 | +26.1% | 52,268 | -75.0% | 0.29% | -5.8% |
| Q4 2018 | $590,000 | +79.9% | 209,195 | +119.8% | 0.31% | +113.7% |
| Q3 2018 | $328,000 | – | 95,185 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |